Literature DB >> 27280602

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Daniel J Fullen, Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W Borley, Anthony Gilbert, Rob Lambkin-Williams.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0145902.].

Entities:  

Year:  2016        PMID： 27280602      PMCID： PMC4900605          DOI： 10.1371/journal.pone.0157211

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


Fig 11, “Mean mucus weight by day in all subjects in the Human Viral Challenge Model.” is a duplicate of Fig 9, “Mean symptom score by day in symptom positive subjects in the Human Challenge Viral Model.” Please view the correct Fig 11 here.
Fig 11

Mean mucus weight by day in all subjects in the Human Viral Challenge Model.

  1 in total

1.  Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Authors:  Daniel J Fullen; Nicolas Noulin; Andrew Catchpole; Hosnieh Fathi; Edward J Murray; Alex Mann; Kingsley Eze; Ganesh Balaratnam; Daryl W Borley; Anthony Gilbert; Rob Lambkin-Williams
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240
  1 in total
  2 in total

Review 1.  The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics.

Authors:  Rob Lambkin-Williams; Nicolas Noulin; Alex Mann; Andrew Catchpole; Anthony S Gilbert
Journal:  Respir Res       Date:  2018-06-22

Review 2.  The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process.

Authors:  Andrew P Catchpole; Daniel J Fullen; Nicolas Noulin; Alex Mann; Anthony S Gilbert; Rob Lambkin-Williams
Journal:  BMC Res Notes       Date:  2018-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.